![Paul van der Horst](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul van der Horst
Chairman at MOLECURE S.A.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Paolo Michieli | M | - |
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | 7 years |
Marta Borkowska | F | - | 11 years | |
Pawel Dobrzanski | M | - | - | |
Zbigniew Zaslona | M | - | - | |
Tim Knotnerus | M | - |
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | 5 years |
Marcin Jan Szumowski | M | - | 12 years | |
Samson Fung | M | - | 2 years | |
Nancy van Osselaer | M | - | 2 years | |
Marta Dudek | M | - | 3 years | |
Anna Bajera | F | - | - | |
John Sørensen Haurum | M | 61 |
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | 5 years |
Slawomir Piotr Broniarek | M | 50 | 9 years | |
Ohad Hammer | M | - |
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | - |
Agnieszka Rajczuk-Szczepanska | F | 53 | - | |
Tomasz Piec | M | - | 3 years | |
Michael Lee | M | 45 |
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | - |
Pawel Trawkowski | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Adam Golebiowski | M | - | 11 years | |
Mariusz Ryszard Gromek | M | 63 | - | |
Nicolas Beuzen | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
Poland | 15 | 75.00% |
Belgium | 5 | 25.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul van der Horst
- Personal Network